April 2002
Volume 43, Issue 4
Free
Physiology and Pharmacology  |   April 2002
Enhancement of HCO3 Permeability across the Apical Membrane of Bovine Corneal Endothelium by Multiple Signaling Pathways
Author Affiliations
  • Yan Zhang
    From the School of Optometry, Indiana University, Bloomington, Indiana.
  • Qiang Xie
    From the School of Optometry, Indiana University, Bloomington, Indiana.
  • Xing Cai Sun
    From the School of Optometry, Indiana University, Bloomington, Indiana.
  • Joseph A. Bonanno
    From the School of Optometry, Indiana University, Bloomington, Indiana.
Investigative Ophthalmology & Visual Science April 2002, Vol.43, 1146-1153. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yan Zhang, Qiang Xie, Xing Cai Sun, Joseph A. Bonanno; Enhancement of HCO3 Permeability across the Apical Membrane of Bovine Corneal Endothelium by Multiple Signaling Pathways. Invest. Ophthalmol. Vis. Sci. 2002;43(4):1146-1153.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

purpose. In this study, the involvement of signaling pathways in the regulation of HCO3 permeability across the apical membrane of the corneal endothelium was examined.

methods. Cultured bovine corneal endothelial cells (CBCECs) were grown to confluence on permeable membranes. Apical and basolateral sides were perfused with a HCO3 -rich Cl-free Ringer’s solution (28.5 mM; pH 7.5). Relative changes in apical HCO3 permeability were assayed by pulsing the apical perfusion bath with a low-HCO3 Cl-free Ringer’s solution (2.85 mM; pH 6.5), in the presence or absence of agonists or inhibitors, and comparing the rates of change in intracellular pH (pHi), as measured with a pH-sensitive dye. Ca2+-activated signaling was measured with the Ca2+-sensitive dye Fura-2. Qualitative changes in membrane potential (Em) were measured with a voltage-sensitive dye. RT-PCR using calcium–activated chloride channel (CLCA)–specific primers was used to examine the expression of CLCA in the corneal endothelium.

results. The adenoceptor agonist adenosine (20 μM) enhanced HCO3 permeability by a factor of 2. Forskolin (40 μM) exerted a 6.3-fold increase of HCO3 permeability, which was inhibited by the Cl channel blockers, glibenclamide (50 μM) and niflumic acid (100 μM). Adenosine triphosphate (ATP) and ATPγS, P2 receptor agonists that increased intracellular Ca2+ in corneal endothelium, enhanced HCO3 permeability by 87% and 79%, respectively. ATPγS induced depolarization of the Em, consistent with anion channel activation, rather than activation of Ca2+-dependent K+ channels, which could secondarily increase extrusion of anions by Em hyperpolarization. Cyclopiazonic acid (CPA), an endoplasmic reticulum (ER) Ca2+-pump inhibitor that increased [Ca2+]i, also enhanced HCO3 permeability by 95%. Both the calmodulin kinase II (CaMKII) inhibitor KN-62 and the PKC inhibitor bisindolylmaleimide I (BIMI), decreased HCO3 permeability induced by ATPγS. The PKC activator PMA also increased HCO3 permeability by a factor of 1.8. RT-PCR using CLCA-specific primers showed the expression of CLCA1 in both fresh and cultured BCECs.

conclusions. Activation of adenoceptors and purinoceptors enhances HCO3 permeability across the apical membrane of the cultured corneal endothelium. Multiple signaling pathways (PKA, PKC, and Ca2+/CaMKII) contribute to the HCO3 transport in cultured corneal endothelium. Both cAMP and Ca2+-activated Cl channels (possibly CLCA) may be involved in HCO3 transport.

The corneal endothelium is a thin monolayer of cells covering the posterior surface of the cornea. 1 2 Its primary function is to maintain corneal transparency through active transport of ions and fluid. The glycosaminoglycans of the corneal stroma exert a net swelling pressure that offers a constant potential fluid imbibition by the stroma. This fluid influx is counterbalanced by the endothelium with an ion-coupled fluid transport mechanism directed from stroma to aqueous humor. Numerous studies have shown that endothelial fluid transport is dependent on the presence of HCO3 . 3 Studies in the past two decades have revealed at least four mechanisms that support HCO3 transport: (1) a potent Na+-dependent, 4,4′-diisothiocyanostilbene-2,2′-disulfonic acid (DIDS)-sensitive, electrogenic Na+-nHCO3 cotransporter (NBC) on the basolateral membrane 3 4 5 ; (2) a Cl-HCO3 exchanger 6 ; (3) anion/Cl channels on the apical membrane 7 ; and (4) cytosolic and membrane-bound carbonic anhydrases (CAs). 4 All these mechanisms have been demonstrated to exist in both fresh and cultured bovine corneal endothelial cells (BCECs), although the Cl-HCO3 exchange activity is weak in cultured corneal endothelium. 6 It is well established that HCO3 enters the cell through the basolateral NBC. We have previously shown that basolateral HCO3 permeability is significantly higher than apical. 4 Thus, the rate-limiting step in transendothelial HCO3 transport is at the apical membrane. We speculate that, most probably, apical HCO3 permeability is controlled by Cl channels and/or CAs. 4  
We have recently shown that the cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in fresh and cultured BCECs. 8 CFTR, which is activated by cAMP, has been shown to have substantial permeability to HCO3 , 9 which may be involved in some of the pathogenic aspects of CF. Further, recent studies have identified some CF-causing mutants that demonstrate normal Cl channel activity but impaired HCO3 transport. 9 Thus, it is possible that CFTR has a significant role in HCO3 transport in corneal endothelium. It is well known that adenosine, which increases cAMP through the A2 receptor can increase the ion and fluid transport across the corneal endothelium. 10 Our previous studies have also shown that Cl and HCO3 permeabilities are enhanced by cAMP in the cultured corneal endothelium. 7 Thus, we hypothesize that adenosine can also enhance HCO3 permeability across the apical membrane of BCECs by activating the cAMP-PKA signaling pathway. 
Agonists of P2 purinergic receptors have been shown to mobilize Ca2+ in corneal endothelial cells. 11 HCO3 has also been demonstrated to permeate a Ca2+-dependent anion channel in gallbladder. 12 Therefore, we also investigated whether HCO3 permeability across the apical membrane can be activated by a Ca2+-signaling mechanism. One possible candidate for HCO3 permeability is the calcium-activated chloride channel (CLCA). 13 14 15 RT-PCR was used to determine the expression of CLCA at the mRNA level. Furthermore, activation of P2 receptors can also generate diacylglycerol (DAG), which will activate PKC. Last, because constitutive phosphorylation by cellular PKC is a prerequisite for the activation of CFTR by PKA, 16 17 we tested to determine whether PKC is involved in HCO3 permeability across the apical membrane. 
Materials and Methods
Cell Culture
Bovine corneal endothelial cells (BCECs) were cultured to confluence on 13-mm permeable membranes (Whatman Anodisc; Fisher Scientific, Fairlawn, NJ) as previously described. 6 18 Briefly, primary cultures from fresh bovine eyes were established in T-25 flasks in 3 mL DMEM, 10% bovine calf serum with antibiotic-antimycotic agents (100 U/mL penicillin, 100 μg/mL streptomycin, and 0.25 μg/mL amphotericin B), gassed with 5% CO2-95% air at 37°C, and fed every 2 to 3 days. These cells were subcultured to three T-25 flasks and grown to confluence in 5 to 7 days. The resultant second-passage cultures were subcultured onto 13-mm permeable filters, reaching confluence within 7 days. Cells were transferred to 0.5% serum-DMEM for at least 24 hours before the experiments began. 
Solutions and Chemicals
The composition of the HCO3 -rich (bicarbonate-rich; BR) Ringer’s solution was (in millimolar) 150 Na+, 4 K+, 0.6 Mg2+, 1.4 Ca2+, 118 Cl, 1 HPO2− 4, 10 HEPES, 28.5 HCO3 , 2 gluconate, and 5 glucose. Ringer’s solutions were equilibrated with 5% CO2, and pH was adjusted to 7.50 at 37°C. Low-HCO3 (low bicarbonate; LB) Ringer’s solution (2.85 mM; pH 6.5) was prepared by replacing 25.65 mM NaHCO3 with sodium gluconate. Cl-free Ringer’s was prepared by equimolar replacement of NaCl with sodium gluconate. Osmolarity was adjusted to 300 ± 5 mOsm with sucrose. 2′,7′-Bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM), bis-oxonol (DiBac4), and Fura-2 acetoxymethyl ester (AM) were obtained from Molecular Probes (Eugene, OR), cell culture supplies from Gibco BRL (Grand Island, NY), and all other chemicals from Sigma (St. Louis, MO). Stock solutions of BCECF-AM (10 mM in DMSO) and nigericin (10 mM in ethanol) were stored desiccated at −20°C. 
Perfusion
For independent perfusion of the apical and basolateral sides of cell-coated filters (Anodisc; Fisher Scientific), a double-sided perfusion chamber was used. 6 The assembled chamber was placed on a water-jacketed (37°C) brass collar held on the stage of an inverted microscope (Diaphot; Nikon, Melville, NY). The apical side was viewed with a long-working-distance objective (×40, 1.2-mm working distance, 0.75 NA; Carl Zeiss, Oberkochen, Germany). The apical and basolateral compartments were connected to separate sections of tubing (Phar-Med; Fisher Scientific), which, in turn, were connected to syringes containing Ringer’s in a Plexiglas warming box (37°C). Both HCO3 -rich and low-HCO3 Ringer’s solutions were continually bubbled with 5% CO2. The flow of the perfusate (∼0.5 mL/min) was achieved by gravity. Two independent eight-way valves were used to select the desired perfusate for the apical and basolateral chambers. 
Measurements of Intracellular pH
Intracellular pH (pHi) was measured with the pH-sensitive fluorescent dye BCECF as previously described. 4 Fluorescence ratios (F495-F440) obtained at 1 second were calibrated against pHi by the high-K+–nigericin technique. Initial rates of intracellular pH over time (dpHi/dt; i.e., maximum slope) were measured for 20 seconds after initial responses or pHi decreases. 
Measurements of Intracellular Ca2+
Intracellular Ca2+ ([Ca2+]i) was measured with Fura-2, a calcium-sensitive fluorescent dye. The cells were loaded by incubation in Ringer’s solution containing 5 μM Fura-2-AM for 30 minutes at room temperature, followed by a wash for 45 minutes. Ca2+ measurements were performed at room temperature with a fluorescence imaging system (MetaFluor; Universal Imaging Co., West Chester, PA). Fluorescence emission at 505 nm was monitored with excitation at 340 and 380 nm. 
Measurements of Membrane Potential
Bis-oxonol, a voltage-sensitive fluorescent dye, was used to measure relative changes in membrane potential (Em). Depolarization partitions the dye into the plasma membrane, making it more fluorescent. Hyperpolarization releases the dye from the membrane, resulting in a decrease of fluorescence. For continuous Em measurements, bis-oxonol was included in the perfusing Ringer’s solutions at a concentration of 200 nM. The bis-oxonol fluorescence was excited at 495 ± 10 nm and the emission collected through a barrier filter centered at 520 ± 20 nm. 
Reverse Transcription–Polymerase Chain Reaction
Total RNA was extracted from cultured and fresh bovine corneal endothelium using extraction reagent (TRIzol; Gibco BRL), according to the manufacturer’s instructions. Total RNA extracted from fresh bovine corneal epithelium served as a positive control. To generate the first-strand cDNA, extracted total RNA (0.5–5 μg) was reverse-transcribed (total incubation mixture, 20 μL) at 42°C for 50 minutes in first-strand buffer (50 mM Tris, 75 mM KCl, and 3.0 mM MgCl2 [pH 8.4]) that contained 10 mM dithiothreitol, 0.5 mM of each dNTP, oligo dT (3 μg/uL, 1.5 μL; Gibco BRL), and reverse transcriptase (40 U/μL, SuperScript II RT; Gibco BRL). First-strand cDNA was used in PCR amplification reactions (total incubation mixture, 25 μL) in a reaction buffer that contained 20 mM Tris (pH 8.4), 50 mM KCl, 2.0 mM MgCl2, 2.5 units polymerase (Ex Taq; TaKaRa Shuzo, Kyoto, Japan), and 0.2 mM of each dNTP, with the specific primer set. Bovine CLCA1- and CLCA2-specific primers (TC-1 and -3 and Lu-1 and -3, respectively) were synthesized according to Elble et al. 14 The final concentration of primers was 0.1 μM. Ultrapure water (Nanopure Filtration Systems; Barnstead International, Dubuque, IA) water substituted for first-strand cDNA served as the negative control. 
PCR amplifications were performed in a thermocycler under the following conditions: denaturation at 94°C for 3 minutes for one cycle, 30 cycles of denaturation at 94°C for 1 minute each, annealing at 61°C for 1 minute, extension at 72°C for 2 minutes, and a final extension for one cycle at 72°C for 15 minutes. The PCR products were loaded onto 1% agarose gel, electrophoresed, and stained with 0.5 μg/mL ethidium bromide. 
Subcloning and Sequencing
The PCR product was purified with a gel extraction kit (Valencia, Chatsworth, CA). Freshly purified products were mixed for 5 minutes with a vector (pcDNA3.1/V5-His TOPO; Invitrogen, San Diego, CA). The cloning reaction was added into a vial of cells (One Shot; Invitrogen) for plasmid transformation. The transformed bacteria were plated on agar culture media that contained ampicillin (50 μg/mL) and incubated at 37°C overnight. The vectors with predicted inserts were isolated using a plasmid miniprep kit (Qiagen, Valencia, CA). Sequencing was performed using a dye terminator cycle-sequencing, ready-reaction mix (Prism BigDye kit; PE-Applied Biosystems, Foster City, CA) according to the manufacturer’s instructions. Sequencing electrophoresis was run on a DNA sequencer (Prism 377; PE-Applied Biosystems) at the Indiana University Molecular Biology Institute. Sequences were assembled and compared on computer (Vector NTI version 5.2 software; InforMax, Bethesda, MD). 
Statistics
Initial slopes of the descending pHi responses for the first 20 seconds during LB pulses were calculated and served as a relative measure of HCO3 permeability across the apical membrane. Quantitation of the pHi changes is expressed as the mean ± SE. Paired t-test was used for statistical analysis and P < 0.05 was considered significant. 
Results
Regulation of HCO3 Permeability across the Apical Membrane by the cAMP-PKA Pathway
In this study, we intended to characterize the signaling pathways involved in HCO3 transport across the apical side of cultured bovine corneal endothelial cells (CBCECs). We have shown that adenosine and forskolin enhance chloride and HCO3 permeability in BCECs cultured on coverslips. 7 Because chloride ions can compete with HCO3 to permeate anion channels, 4 7 we used chloride-free Ringer’s solution in all experiments to measure HCO3 permeability. Furthermore, the use of Cl-free (gluconate-substituted) solutions eliminated any possible involvement of anion exchanger activity in our HCO3 permeability measurements. To measure relative changes in apical HCO3 permeability, we used a constant CO2 protocol. 4 Constant [CO2] on both sides removes any effect on pHi due to rapidly diffusing CO2. Permeable filter–raised cultures perfused in a double-sided chamber were exposed to a BR Cl-free solution (5% CO2, 28.5 mM HCO3 [pH 7.5]) on the basolateral and apical sides at 37°C. Apical perfusion was then quickly changed to an LB Cl-free solution (5% CO2, 2.85 mM HCO3 [pH 6.5]). 
Because the CO2 concentration is the same on both sides, pHi was affected by HCO3 efflux and H+ influx across the apical membrane. It has been shown that only 18% of the initial dpHi/dt is due to H+ fluxes. 4 Considering that the amplitude of pHi changes during LB pulses may be influenced by basolateral transporters such as NBC, we used only the initial rate of pHi change instead of the amplitude as the criteria for comparison of HCO3 permeability across the apical membrane in the presence or absence of applied agents. When BR was replaced by LB on the apical side, pHi decreased significantly (Fig. 1A) . After decreasing, pHi stabilized or recovered slightly to a level that was still much lower than the baseline pHi before readdition of BR. Readdition of BR caused a small decline in pHi before it increased to baseline. These pHi changes during LB pulses are consistent with our previous study. 4 Two sequential LB pulses in the absence of test drugs appeared to have the same initial dpHi/dt (P = 0.335, n = 5, not shown). In this study, DMSO was often used to solubilize test drugs, and so we tested the effects of DMSO on HCO3 permeability. After a control pulse, the second pulse was performed in the presence of 0.5% (vol/vol) DMSO in perfusion solutions. The initial dpHi/dt for the two LB pulses were not significantly different (data not shown, P = 0.614, n = 7), indicating that DMSO did not affect HCO3 permeability. 
When 20 μM adenosine was applied in the BR solution, baseline pHi decreased 0.033 ± 0.008 pH units (n = 7; Fig. 1A ). Furthermore, in the presence of adenosine, the LB pulse caused an increased rate of pHi change by a factor of 1.98 ± 0.20, compared with the control LB pulse (n = 7, P < 0.005, Fig. 1B ). These results suggest that apical HCO3 permeability can be enhanced by a cAMP-mediated process. 
We further examined whether forskolin, a potent activator of adenylate cyclase could increase apical HCO3 permeability. As shown in Figure 1C , after application of 40 μM forskolin, an immediate sharp decrease in pHi (0.096 ± 0.023, n = 6) was observed, which gradually reached a new steady state level below baseline (0.097 ± 0.013, n = 6). After pHi became stable, a second LB pulse was made in the continued presence of 40 μM forskolin. The rate of pHi decline was 6.3 ± 2.2 times faster than in the control (P < 0.005, n = 6, Fig. 1D ), indicating that increasing cAMP leads to a significant increase in apical HCO3 permeability. 
To test whether HCO3 is transported through cAMP-activated chloride channels, we used the chloride channel blockers niflumic acid and glibenclamide in the presence of forskolin stimulation. After application of 100 μM niflumic acid or 50 μM glibenclamide, pHi increased (Figs. 2A 2C ; 0.094 ± 0.008, n = 4 and 0.067 ± 0.016, n = 5, respectively). Niflumic acid and glibenclamide significantly inhibited forskolin-activated dpHi/dt by 94.8% ± 1.4% and 51% ± 10% (P < 0.005, n = 4; P < 0.01, n = 5, respectively; Figs. 2B 2D ). After removing niflumic acid or glibenclamide, the effects of the inhibition were totally reversed by 10 to 15 minutes of washout (Figs. 2A 2C) . The inhibitory effects of chloride channel blockers are consistent with the presence of HCO3 -permeable anion channels in BCECs. 
Regulation of HCO3 Permeability across the Apical Membrane by the Ca2+-Signaling Pathway
We attempted to examine whether Ca2+ signaling is involved in HCO3 permeability on the apical membrane in the corneal endothelium by stimulating purinergic receptors, because this has been shown to increase [Ca2+]i in cultured CBCECs. ATP (100 μM) induced [Ca2+]i responses (not shown) similar to those reported previously with BCECs cultured on coverslips. 11 The response includes a peak and a plateau elevation, which are thought to be primarily composed of Ca2+ mobilization and capacitative calcium entry, respectively. 19 ATP (100 μM) also decreased baseline pHi gradually (0.04 ± 0.019, n = 6; Fig. 3A ). The second LB pulse in the presence of ATP induced an 87% ± 27% increase in dpHi/dt (Figs. 3A 3D) . ATP may be converted to adenosine by cell surface ecto-adenosine triphosphatases (ATPases; CD39). 20 To exclude the possibility that the increased HCO3 permeability is due to adenosine, we used ATPγS, a nonhydrolyzable analogue of ATP, as the purinergic receptor agonist. ATPγS (100 μM) also induced a biphasic [Ca2+]i elevation (not shown). Application of 100 μM ATPγS decreased pHi immediately by 0.047 ± 0.009 (n = 7). The second LB pulse in the presence of ATPγS showed a 79% ± 12% increase in dpHi/dt (Figs. 3B 3D) , indicating that elevated [Ca2+]i can lead to increased apical HCO3 permeability. 
To further confirm the involvement of Ca2+ signaling in regulation of HCO3 permeability, we used an alternative strategy to increase [Ca2+]i. Cyclopiazonic acid (CPA) is a sarcoendoplasmic reticulum Ca2+-ATPase (SERCA) inhibitor, which depletes the calcium store and causes further Ca2+ entry through store-operated calcium channels (SOCs) causing capacitative calcium entry (CCE). 19 CPA (20 μM) caused a two-phase Ca2+ increase, which is composed of a peak and an elevated sustained plateau (not shown). This response is also consistent with previous reports. 11 Application of 20 μM CPA decreased pHi, followed by a slow settling of pHi back to the baseline. The second LB pulse in the presence of CPA showed an increase in dpHi/dt 1.95 ± 0.24 times greater than in the control (Figs. 3C 3D)
Another possibility for the Ca2+-induced apparent increase in HCO3 permeability is an increased driving force for HCO3 efflux through Em hyperpolarization caused by Ca2+-activated K+ channels. If this were the case, we would expect a hyperpolarization during the [Ca2+]i elevation by ATPγS. A depolarization would be an indication of increased anion (HCO3 ) channel permeability. Therefore, we measured the Em with the voltage-sensitive dye bis-oxonol. Under Cl-rich conditions (Fig.4) , ATPγS depolarized the Em for approximately 10 minutes, and then the Em repolarized to baseline (n = 4). Under Cl-free conditions, we observed similar, but smaller, changes in Em (not shown). These results support a more direct role of Ca2+ in anion channel permeability, rather than as an increased driving force for HCO3 efflux through Em hyperpolarization. 
Increased [Ca2+]i has been shown to activate chloride channels through calmodulin kinases (CaMK). 15 In this study, we examined whether CaMKs are involved in the regulation of HCO3 permeability by using the CaMKII-specific inhibitor KN-62. 21 It has been reported that CaMKII is ubiquitously present in mammalian tissues. 22 Figure 5A shows a control response to LB and a response in the presence of both ATPγS and KN-62. The initial dpHi/dt in the presence of both ATPγS (100 μM) and KN-62 (2 μM) was much slower than in the presence of ATPγS (100 μM) alone (Fig. 3B) . Figure 5B summarizes these results, showing that KN-62 in the presence of ATPγS inhibited the initial dpHi/dt by 49% ± 9% compared with the control. We also found that LB-induced apical HCO3 efflux was inhibited 60% ± 6% by KN-62 alone (P < 0.01, n = 3, data not shown), which indicates that CaMK phosphorylation may be a potentiating factor, even in resting cells. 
The Expression of CLCA in Corneal Endothelial Cells
Recently, two CLCA genes have been described. 13 14 To examine the expression of CLCA genes in the corneal endothelial cells, we used bovine (b)CLCA1 and bCLCA2 (lung-endothelial cell adhesion molecule (Lu-ECAM)-1)-specific primers in RT-PCR for fresh and cultured BCECs. It has been reported that CLCA1 is expressed in the corneal epithelium, 23 which we used as a positive control. Our RT-PCR results showed expression of bCLCA1 in both fresh and cultured BCECs (Fig. 6) , whereas bCLCA2 mRNA was not detected (data not shown). Sequencing of the PCR product (231 bp) showed 99% homology to published bCLCA1. The detection of mRNA expression of bCLCA1 in the fresh and cultured corneal endothelial cells is consistent with our data showing Ca2+-dependent HCO3 permeability. 
Possible Regulation of HCO3 Permeability across the Apical Membrane by PKC
Activation of phospholipase C can activate PKC through DAG or Ca2+. 24 Furthermore, PKC can potentiate the activity of CFTR. 16 17 Because of the permeability of CFTR to HCO3 , we hypothesized that PKC activation induced by purinoceptor agonists may be one of the signaling pathways leading to HCO3 permeability. To examine the involvement of PKC in HCO3 permeability regulation, we tested the effects of phorbol 12-myristate 13-acetate (PMA), a potent PKC activator, and its ineffective analogue, 4α-phorbol 12-myristate 13-acetate. LB pulses in the presence of PMA (1 μM) increased dpHi/dt by 79% ± 29% (P < 0.01, n = 9; Fig. 7A 7B ), whereas the PMA analogue (1 μM) appeared to have no significant effect (P > 0.05, n = 6). We also applied ATPγS together with bisindolylmaleimide I (BIMI), a specific PKC inhibitor. 25 Combined application of ATPγS and BIMI (1 μM) significantly inhibited dpHi/dt by 71% ± 7% (n = 4; Fig 8A ) compared with control, whereas ATPγS alone increased dpHi/dt by 79% ± 12% (Figs. 3B 3D 8B) . We also found that LB-induced apical HCO3 efflux was inhibited 50% by BIMI alone (P [lt] 0.05, n = 6, not shown). Moreover, in the presence of BIMI, forskolin did not enhance HCO3 permeability (not shown). These results are consistent with the prerequisite role of PKC in CFTR activation and indicate that PKC is one of the signaling pathways for HCO3 permeability regulation. 
Discussion
In this study, we showed for the first time that activation of purinergic receptors can enhance apical HCO3 permeability in corneal endothelial cells, possibly through Ca2+-CaMKII- and PKC-signaling pathways, and that CLCA1 is expressed in the corneal endothelium. Together with the stimulatory effect of cAMP-PKA on HCO3 permeability, multiple pathways including Ca2+-CaMKII and PKC can converge to cause the upregulation of HCO3 permeability. 
We used a two-LB pulse, constant CO2 protocol to examine the effects of intervention drugs on HCO3 permeability across the apical membrane of the corneal endothelium. During the initial part of apical LB perfusion, HCO3 leaves the cell and H+ enters from the bath across the apical membrane. Because more than 80% of the initial dpHi/dt is due to HCO3 flux, 4 we can use this rate as a relative measure of HCO3 flux. Further, because the experiments are paired and the driving force for HCO3 efflux is the same during control and test pulses, the differences in initial dpHi/dt reflect differences in HCO3 permeability. 
Both the adenoceptor agonist adenosine and AC activator forskolin enhanced HCO3 permeability across the corneal endothelium. Adenosine has been used as a stimulator of ion and fluid transport across the corneal endothelium for 30 years. 10 26 27 Adenosine binds to A2 receptors leading to activation of the cAMP pathway. We have shown that cAMP activates Cl permeability across cultured BCECs. 7 Our current results show that forskolin increased HCO3 permeability across the apical membrane (Fig. 2) . The upregulation of HCO3 permeability by the cAMP pathway is not surprising. We recently found that CFTR, a cAMP-activated chloride channel, is expressed in corneal endothelial cells. 8 Preliminary studies from our laboratory indicate that CFTR is localized only to the apical membrane of the corneal endothelium (Sun XC, written communication, August 2001). The apical localization of CFTR is consistent with our observation that adenosine and forskolin can enhance HCO3 permeability across the apical membrane. Thus, the immediate decrease of pHi caused by either adenosine or forskolin may be due to activation of a cAMP-dependent anion channel, causing a quick increase in HCO3 efflux from the cell (Fig. 1C) . The reduced pHi and Em depolarization would both lead to increased basolateral HCO3 influx through the electrogenic NBC, which may explain the following transient pHi fluctuations. The Cl channel blockers glibenclamide and niflumic acid inhibited the increased HCO3 permeability induced by forskolin, indicating the involvement of Cl channels in HCO3 transport (Fig. 2)
ATP, ATPγS, and CPA also enhanced HCO3 permeability. All these agents increased [Ca2+]i. ATPγS depolarized Em (Fig. 4) , consistent with increased anion conductance. After the depolarization in the continued presence of ATP, Em repolarized. This may indicate that increased [Ca2+]i also activates K+ channels, thereby maintaining the driving force for HCO3 efflux. Ca2+-activated chloride channels have been cloned in the bovine tracheal epithelium and lung endothelium. 13 14 HCO3 has also been demonstrated to permeate a Ca2+-dependent anion channel in gallbladder. 12 Our RT-PCR results showed the expression of bCLCA1 in the fresh and cultured corneal endothelial cells (Fig. 6) . This is consistent with the enhancing effects of ATP, ATPγS, and CPA on HCO3 permeability. Further, studies on the expression and localization of CLCA are needed to determine the role of CLCA in corneal endothelial HCO3 transport. 
Constitutive phosphorylation of CFTR by PKC is thought to be required for subsequent CFTR activation by PKA. 16 17 Due to the permeability of CFTR to HCO3 , it is not surprising that the PKC specific inhibitor BIMI inhibited HCO3 permeability dramatically, even in the presence of ATPγS (Fig. 8) . The enhanced HCO3 permeability caused by the PKC activator PMA further confirms the importance of PKC phosphorylation in the regulation of HCO3 permeability in BCECs (Fig. 7)
Because the corneal endothelium is essential for the dehydration and transparency of the cornea, the regulation of the transport functions of this monolayer would have significant effects on the hydration of the cornea. Involvement of multiple pathways and receptor systems has the advantage of using multiple factors to enhance the transport function of the corneal endothelium. In addition to the adenoceptor-cAMP-PKA mechanism, activation of purinergic receptors can enhance HCO3 permeability through both Ca2+ and PKC pathways. Purinoceptor agonists lead to a two-phase [Ca2+]i elevation, including Ca2+ mobilization from the endoplasmic reticulum (ER) through IP3 receptors and Ca2+ entry through store-operated calcium channels. Ca2+ may activate CLCA through CaMKII. However, we could not exclude the possibility that Ca2+ can directly activate CLCA. Furthermore, activation of purinoceptors can stimulate PKC through Ca2+ or DAG, which also increased HCO3 permeability, probably through activation of CFTR. 
 
Figure 1.
 
Adenosine and forskolin enhanced apical HCO3 permeability across CBCECs. CBCECs grown on permeable membranes were loaded with the pH-sensitive fluorescent dye BCECF. Apical and basolateral compartments were perfused with bicarbonate-rich, chloride-free Ringer’s. Black boxes: LB pulse applied to the apical side. (A) Effects of adenosine (20 μM) on HCO3 permeability. (B) Comparison of the initial rates of pHi changes (dpHi/dt) between the control and adenosine LB pulses. (C) Effects of forskolin (40 μM) on HCO3 permeability. (D) Comparison of the initial dpHi/dt between the control and forskolin LB pulses.
Figure 1.
 
Adenosine and forskolin enhanced apical HCO3 permeability across CBCECs. CBCECs grown on permeable membranes were loaded with the pH-sensitive fluorescent dye BCECF. Apical and basolateral compartments were perfused with bicarbonate-rich, chloride-free Ringer’s. Black boxes: LB pulse applied to the apical side. (A) Effects of adenosine (20 μM) on HCO3 permeability. (B) Comparison of the initial rates of pHi changes (dpHi/dt) between the control and adenosine LB pulses. (C) Effects of forskolin (40 μM) on HCO3 permeability. (D) Comparison of the initial dpHi/dt between the control and forskolin LB pulses.
Figure 2.
 
Glibenclamide and niflumic acid inhibited the FSK-induced enhancement of HCO3 permeability across the apical side of CBCECs. (A) Effect of niflumic acid (100 μM) on forskolin-stimulated HCO3 permeability. (B) Comparison of the initial dpHi/dt between LB pulses in the presence of forskolin alone and forskolin plus niflumic acid (NA). Black boxes: LB pulses applied to the apical side. (C) The effects of glibenclamide (GB; 50 μM) on forskolin-enhanced HCO3 permeability. (D) Comparison of the initial dpHi/dt between LB pulses in the presence of forskolin alone and forskolin plus glibenclamide.
Figure 2.
 
Glibenclamide and niflumic acid inhibited the FSK-induced enhancement of HCO3 permeability across the apical side of CBCECs. (A) Effect of niflumic acid (100 μM) on forskolin-stimulated HCO3 permeability. (B) Comparison of the initial dpHi/dt between LB pulses in the presence of forskolin alone and forskolin plus niflumic acid (NA). Black boxes: LB pulses applied to the apical side. (C) The effects of glibenclamide (GB; 50 μM) on forskolin-enhanced HCO3 permeability. (D) Comparison of the initial dpHi/dt between LB pulses in the presence of forskolin alone and forskolin plus glibenclamide.
Figure 3.
 
ATP, ATPγS, and CPA enhanced HCO3 permeability across the apical side of CBCECs. (A) The effects of ATP (100 μM; n = 6), (B) ATPγS (100 μM; n = 7), and (C) CPA (20 μM; n = 7) on apical HCO3 permeability. Black boxes: LB pulses applied to the apical side. (D) Summary of the effects of ATP, ATPγS, and CPA on initial dpHi/dt during LB pulses.
Figure 3.
 
ATP, ATPγS, and CPA enhanced HCO3 permeability across the apical side of CBCECs. (A) The effects of ATP (100 μM; n = 6), (B) ATPγS (100 μM; n = 7), and (C) CPA (20 μM; n = 7) on apical HCO3 permeability. Black boxes: LB pulses applied to the apical side. (D) Summary of the effects of ATP, ATPγS, and CPA on initial dpHi/dt during LB pulses.
Figure 4.
 
The effects of ATPγS (100 μM) on Em. Cells were perfused in HCO3 - and Cl-rich solutions containing 200 nM bis-oxonol. Increasing fluorescence indicates depolarization of Em, and decreasing fluorescence indicates hyperpolarization of Em.
Figure 4.
 
The effects of ATPγS (100 μM) on Em. Cells were perfused in HCO3 - and Cl-rich solutions containing 200 nM bis-oxonol. Increasing fluorescence indicates depolarization of Em, and decreasing fluorescence indicates hyperpolarization of Em.
Figure 5.
 
The CaMKII inhibitor KN-62 inhibited ATPγS-enhanced apical HCO3 permeability across CBCECs. (A) The effects of the CaMKII inhibitor KN-62 were studied by simultaneous application of ATPγS (100 μM) and KN-62 (2 μM). Black boxes: LB pulses applied to the apical side. (B) Comparison of the effects of ATPγS alone and ATPγS together with KN-62 on initial dpHi/dt during LB pulses.
Figure 5.
 
The CaMKII inhibitor KN-62 inhibited ATPγS-enhanced apical HCO3 permeability across CBCECs. (A) The effects of the CaMKII inhibitor KN-62 were studied by simultaneous application of ATPγS (100 μM) and KN-62 (2 μM). Black boxes: LB pulses applied to the apical side. (B) Comparison of the effects of ATPγS alone and ATPγS together with KN-62 on initial dpHi/dt during LB pulses.
Figure 6.
 
RT-PCR analysis of the expression of bCLCA1 in corneal endothelial cells. The expected size is 231 bp. Lane 1: marker; lane 2: fresh epithelium; lane 3: fresh endothelium; lane 4: cultured endothelium; lane 5: negative control.
Figure 6.
 
RT-PCR analysis of the expression of bCLCA1 in corneal endothelial cells. The expected size is 231 bp. Lane 1: marker; lane 2: fresh epithelium; lane 3: fresh endothelium; lane 4: cultured endothelium; lane 5: negative control.
Figure 7.
 
Enhancement of HCO3 permeability across the apical side of CBCECs by PMA. (A) The effects of PMA (1 μM) on apical HCO3 permeability. (B) Summary of the effects of PMA and the PMA analogue (ANA) on initial dpHi/dt during LB pulses. Black boxes: LB pulses applied to the apical side.
Figure 7.
 
Enhancement of HCO3 permeability across the apical side of CBCECs by PMA. (A) The effects of PMA (1 μM) on apical HCO3 permeability. (B) Summary of the effects of PMA and the PMA analogue (ANA) on initial dpHi/dt during LB pulses. Black boxes: LB pulses applied to the apical side.
Figure 8.
 
The PKC inhibitor BIMI inhibits ATPγS-enhanced apical HCO3 permeability across CBCECs. (A) The effects of the PKC inhibitor BIMI were studied by simultaneous application of ATPγS (100 μM) and BIMI (1 μM). (B) Comparison of the effects of ATPγS alone and ATPγS together with BIMI on initial dpHi/dt during LB pulses. Black boxes: LB pulses applied to apical side.
Figure 8.
 
The PKC inhibitor BIMI inhibits ATPγS-enhanced apical HCO3 permeability across CBCECs. (A) The effects of the PKC inhibitor BIMI were studied by simultaneous application of ATPγS (100 μM) and BIMI (1 μM). (B) Comparison of the effects of ATPγS alone and ATPγS together with BIMI on initial dpHi/dt during LB pulses. Black boxes: LB pulses applied to apical side.
The authors thank Miao Cui and Kah Tan Allen for excellent technical support. 
Maurice DM. The location of the fluid pump in the cornea. J Physiol. 1972;221:43–54. [CrossRef] [PubMed]
Maurice DM, Giardini AA. Swelling of the cornea in vivo after the destruction of its limiting layers. Br J Ophthalmol. 1951;35:791–797. [CrossRef] [PubMed]
Riley MV, Winkler BS, Czajkowski CA, Peters MI. The roles of bicarbonate and CO2 in transendothelial fluid movement and control of corneal thickness. Invest Ophthalmol Vis Sci. 1995;36:103–112. [PubMed]
Bonanno JA, Guan Y, Jelamskii S, Kang XJ. Apical and basolateral CO2-HCO3 permeability in cultured bovine corneal endothelial cells. Am J Physiol. 1999;277:C545–C553. [PubMed]
Sun XC, Bonanno JA, Jelamski S, Xie Q. Expression and localization of NaHCO3 cotransporter in bovine corneal endothelium. Am J Physiol. 2000;279:C1648–C1655.
Bonanno JA, Yi G, Kang XJ, Srinivas SP. Reevaluation of Cl-HCO3 exchange in cultured bovine corneal endothelial cells. Invest Ophthalmol Vis Sci. 1998;39:2713–2722. [PubMed]
Bonanno JA, Srinivas SP. Cyclic AMP activates anion channels in cultured bovine corneal endothelial cells. Exp Eye Res. 1997;64:953–962. [CrossRef] [PubMed]
Sun XC, McCutheon C, Bertram P, Xie Q, Bonanno JA. Studies on the expression of mRNA for anion transport related proteins in corneal endothelial cells. Curr Eye Res. 2001;22:1–7. [CrossRef] [PubMed]
Choi JY, Muallem D, Kiselyov K, Lee MG, Thomas PJ, Muallem S. Aberrant CFTR-dependent HCO3 transport in mutations associated with cystic fibrosis. Nature. 2001;410:94–97. [CrossRef] [PubMed]
Riley M, Winkler BS, Starnes CA, Peters MI. Adenosine promotes regulation of corneal hydration through cyclic adenosine monophosphate. Invest Ophthalmol Vis Sci. 1996;37:1–10. [PubMed]
Srinivas SP, Yeh JC, Ong A, Bonanno JA. Ca2+ mobilization in bovine corneal endothelial cells by P2 purinergic receptors. Curr Eye Res. 1998;17:994–1004. [CrossRef] [PubMed]
Clarke LL, Harline MC, Gawenis LR, Walker NM, Turner JT, Weisman GA. Extracellular UTP stimulates electrogenic bicarbonate secretion across CFTR knockout gallbladder epithelium. Am J Physiol. 2000;279:G132–G138.
Cunningham SA, Awayda MS, Bubien JK, et al. Cloning of an epithelial chloride channel from bovine trachea. J Biol Chem. 1995;270:31016–31026. [CrossRef] [PubMed]
Elble RC, Widom J, Gruber AD, et al. Cloning and characterization of lung-endothelial cell adhesion molecule-1 suggest it is an endothelial chloride channel. J Biol Chem. 1997;272:27853–27861. [CrossRef] [PubMed]
Kidd JF, Thorn P. Intracellular Ca2+ and Cl channel activation in secretory cells. Annu Rev Physiol. 2000;62:493–513. [CrossRef] [PubMed]
Jia Y, Mathews CJ, Hanrahan JW. Phosphorylation by protein kinase C is required for acute activation of cystic fibrosis transmembrane permeability regulator by protein kinase A. J Biol Chem. 1997;272:4978–4984. [CrossRef] [PubMed]
Gadsby DC, Nairn AC. Control of CFTR channel gating by phosphorylation and nucleotide hydrolysis. Physiol Rev. 1999;79:S77–S107. [PubMed]
Bonanno JA, Giasson C. Intracellular pH regulation in fresh and cultured bovine corneal endothelium. I: Na/H exchange in the absence and presence of HCO3 . Invest Ophthalmol Vis Sci. 1992;33:3058–3067. [PubMed]
Putney JW, Jr, McKay RR. Capacitative calcium entry channels. Bioessays. 1999;21:38–46. [CrossRef] [PubMed]
Srinivas SP, Mutharasan R, Sun XC, Bonanno JA. Stretch-activated ATP release by corneal endothelium [ARVO Abstract]. Invest Ophthalmol Vis Sci. 2001;42(4)S665.Abstract nr 3579
Hidaka H, Yokokura H. Molecular and cellular pharmacology of a calcium/calmodulin-dependent protein kinase II (CaM kinase II) inhibitor, KN-62, and proposal of CaM kinase phosphorylation cascades. Adv Pharmacol. 1996;36:193–219. [PubMed]
Tobimatsu T, Fujisawa H. Tissue-specific expression of four types of rat calmodulin-dependent protein kinase II mRNAs. J Biol Chem. 1989;264:17907–17912. [PubMed]
Gruber AD, Gandhi R, Pauli BU. The murine calcium-sensitive chloride channel (mCaCC) is widely expressed in secretory epithelia and in other select tissues. Histochem Cell Biol. 1998;110:43–49. [CrossRef] [PubMed]
Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. Molecular Biology of the Cell. 1994; 3rd ed. 747–749. Garland Publishing, Inc New York.
Toullec D, Pianetti P, Coste H, et al. The bisindolylmaleimide GF 109203x is a potent and selective inhibitor of protein kinase C. J Biol Chem. 1991;266:15771–15781. [PubMed]
Dikstein S, Maurice D. The metabolic basis to the fluid pump in the cornea. J Physiol. 1971;221:29–41.
Fischbarg J, Lim JJ, Bourguet J. Adenosine stimulation of fluid transport across rabbit corneal endothelium. J Membr Biol. 1977;35:95–112. [CrossRef] [PubMed]
Figure 1.
 
Adenosine and forskolin enhanced apical HCO3 permeability across CBCECs. CBCECs grown on permeable membranes were loaded with the pH-sensitive fluorescent dye BCECF. Apical and basolateral compartments were perfused with bicarbonate-rich, chloride-free Ringer’s. Black boxes: LB pulse applied to the apical side. (A) Effects of adenosine (20 μM) on HCO3 permeability. (B) Comparison of the initial rates of pHi changes (dpHi/dt) between the control and adenosine LB pulses. (C) Effects of forskolin (40 μM) on HCO3 permeability. (D) Comparison of the initial dpHi/dt between the control and forskolin LB pulses.
Figure 1.
 
Adenosine and forskolin enhanced apical HCO3 permeability across CBCECs. CBCECs grown on permeable membranes were loaded with the pH-sensitive fluorescent dye BCECF. Apical and basolateral compartments were perfused with bicarbonate-rich, chloride-free Ringer’s. Black boxes: LB pulse applied to the apical side. (A) Effects of adenosine (20 μM) on HCO3 permeability. (B) Comparison of the initial rates of pHi changes (dpHi/dt) between the control and adenosine LB pulses. (C) Effects of forskolin (40 μM) on HCO3 permeability. (D) Comparison of the initial dpHi/dt between the control and forskolin LB pulses.
Figure 2.
 
Glibenclamide and niflumic acid inhibited the FSK-induced enhancement of HCO3 permeability across the apical side of CBCECs. (A) Effect of niflumic acid (100 μM) on forskolin-stimulated HCO3 permeability. (B) Comparison of the initial dpHi/dt between LB pulses in the presence of forskolin alone and forskolin plus niflumic acid (NA). Black boxes: LB pulses applied to the apical side. (C) The effects of glibenclamide (GB; 50 μM) on forskolin-enhanced HCO3 permeability. (D) Comparison of the initial dpHi/dt between LB pulses in the presence of forskolin alone and forskolin plus glibenclamide.
Figure 2.
 
Glibenclamide and niflumic acid inhibited the FSK-induced enhancement of HCO3 permeability across the apical side of CBCECs. (A) Effect of niflumic acid (100 μM) on forskolin-stimulated HCO3 permeability. (B) Comparison of the initial dpHi/dt between LB pulses in the presence of forskolin alone and forskolin plus niflumic acid (NA). Black boxes: LB pulses applied to the apical side. (C) The effects of glibenclamide (GB; 50 μM) on forskolin-enhanced HCO3 permeability. (D) Comparison of the initial dpHi/dt between LB pulses in the presence of forskolin alone and forskolin plus glibenclamide.
Figure 3.
 
ATP, ATPγS, and CPA enhanced HCO3 permeability across the apical side of CBCECs. (A) The effects of ATP (100 μM; n = 6), (B) ATPγS (100 μM; n = 7), and (C) CPA (20 μM; n = 7) on apical HCO3 permeability. Black boxes: LB pulses applied to the apical side. (D) Summary of the effects of ATP, ATPγS, and CPA on initial dpHi/dt during LB pulses.
Figure 3.
 
ATP, ATPγS, and CPA enhanced HCO3 permeability across the apical side of CBCECs. (A) The effects of ATP (100 μM; n = 6), (B) ATPγS (100 μM; n = 7), and (C) CPA (20 μM; n = 7) on apical HCO3 permeability. Black boxes: LB pulses applied to the apical side. (D) Summary of the effects of ATP, ATPγS, and CPA on initial dpHi/dt during LB pulses.
Figure 4.
 
The effects of ATPγS (100 μM) on Em. Cells were perfused in HCO3 - and Cl-rich solutions containing 200 nM bis-oxonol. Increasing fluorescence indicates depolarization of Em, and decreasing fluorescence indicates hyperpolarization of Em.
Figure 4.
 
The effects of ATPγS (100 μM) on Em. Cells were perfused in HCO3 - and Cl-rich solutions containing 200 nM bis-oxonol. Increasing fluorescence indicates depolarization of Em, and decreasing fluorescence indicates hyperpolarization of Em.
Figure 5.
 
The CaMKII inhibitor KN-62 inhibited ATPγS-enhanced apical HCO3 permeability across CBCECs. (A) The effects of the CaMKII inhibitor KN-62 were studied by simultaneous application of ATPγS (100 μM) and KN-62 (2 μM). Black boxes: LB pulses applied to the apical side. (B) Comparison of the effects of ATPγS alone and ATPγS together with KN-62 on initial dpHi/dt during LB pulses.
Figure 5.
 
The CaMKII inhibitor KN-62 inhibited ATPγS-enhanced apical HCO3 permeability across CBCECs. (A) The effects of the CaMKII inhibitor KN-62 were studied by simultaneous application of ATPγS (100 μM) and KN-62 (2 μM). Black boxes: LB pulses applied to the apical side. (B) Comparison of the effects of ATPγS alone and ATPγS together with KN-62 on initial dpHi/dt during LB pulses.
Figure 6.
 
RT-PCR analysis of the expression of bCLCA1 in corneal endothelial cells. The expected size is 231 bp. Lane 1: marker; lane 2: fresh epithelium; lane 3: fresh endothelium; lane 4: cultured endothelium; lane 5: negative control.
Figure 6.
 
RT-PCR analysis of the expression of bCLCA1 in corneal endothelial cells. The expected size is 231 bp. Lane 1: marker; lane 2: fresh epithelium; lane 3: fresh endothelium; lane 4: cultured endothelium; lane 5: negative control.
Figure 7.
 
Enhancement of HCO3 permeability across the apical side of CBCECs by PMA. (A) The effects of PMA (1 μM) on apical HCO3 permeability. (B) Summary of the effects of PMA and the PMA analogue (ANA) on initial dpHi/dt during LB pulses. Black boxes: LB pulses applied to the apical side.
Figure 7.
 
Enhancement of HCO3 permeability across the apical side of CBCECs by PMA. (A) The effects of PMA (1 μM) on apical HCO3 permeability. (B) Summary of the effects of PMA and the PMA analogue (ANA) on initial dpHi/dt during LB pulses. Black boxes: LB pulses applied to the apical side.
Figure 8.
 
The PKC inhibitor BIMI inhibits ATPγS-enhanced apical HCO3 permeability across CBCECs. (A) The effects of the PKC inhibitor BIMI were studied by simultaneous application of ATPγS (100 μM) and BIMI (1 μM). (B) Comparison of the effects of ATPγS alone and ATPγS together with BIMI on initial dpHi/dt during LB pulses. Black boxes: LB pulses applied to apical side.
Figure 8.
 
The PKC inhibitor BIMI inhibits ATPγS-enhanced apical HCO3 permeability across CBCECs. (A) The effects of the PKC inhibitor BIMI were studied by simultaneous application of ATPγS (100 μM) and BIMI (1 μM). (B) Comparison of the effects of ATPγS alone and ATPγS together with BIMI on initial dpHi/dt during LB pulses. Black boxes: LB pulses applied to apical side.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×